migratory necrolytic erythema; glucagonoma syndrome; erythema necrolytica migrans

From Aaushi
Jump to navigation Jump to search

Etiology

* rare patients without underlying malignancy[2]

Epidemiology

  • rare
  • middle-aged to elderly

Pathology

Clinical manifestations

Laboratory

Differential diagnosis

Management

  • responds poorly to all forms of therapy
  • partial response in some cases to zinc replacement
  • surgical excision of glucagonoma may improve or resolve symptoms

More general terms

References

  1. Color Atlas & Synopsis of Clinical Dermatology, Common & Serious Diseases, 3rd ed, Fitzpatrick et al, McGraw Hill, NY, 1997, pg 512
  2. 2.0 2.1 2.2 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018.